Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -17.988% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCCOc1ccc(/C(O)=C2\C(=O)C(=O)N(c3ccccn3)C2c2ccccc2F)cc1C
b: Cc1ccc(C(=S)N2CCN(Cc3ccccc3)CC2)cc1
Answer: a. CCCOc1ccc(/C(O)=C2\C(=O)C(=O)N(c3ccccn3)C2c2ccccc2F)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOc1ccc(/C(O)=C2\C(=O)C(=O)N(c3ccccn3)C2c2ccccc2F)cc1C
CCCOc1ccc(/C(O)=C2\C(=O)C(=O)N(c3ccccn3)C2c2ccccc2F)cc1C
(4E)-5-(2-fluorophenyl)-4-[hydroxy-(3-methyl-4-propoxyphenyl)methylidene]-1-pyridin-2-ylpyrrolidine-2,3-dione